Polpharma B2B Manufacturer of Generic Drugs and Active Pharmaceutical Ingredients

Polpharma is a leader on the Polish pharmaceutical market.

Polpharma B2B Unit is a world-class provider of high-quality products and services that offers customised support through its international sales team and experienced research and development (R&D) experts. The company provides you with tailor-made solutions addressing all of your business needs.

Polpharma is one of the leading European manufacturers, with sites located in Poland, the heart of Europe.

It provides a wide range of integrated solutions, including active pharmaceutical ingredients (API), finished dosage formulation (FDF) licensing out and supply and contract manufacturing and contract development and manufacturing organisation (CDMO) services.

Manufacturing of APIs for drug development

Polpharma B2B manufactures APIs at its current good manufacturing practice (cGMP) compliant and US Food and Drug Administration (FDA) approved multipurpose facilities. These plants passed FDA inspections in 2004, 2009, 2012, 2015 and most recently in May 2018.

The company ensures its manufacturing processes are in line with stringent requirements of customers and healthcare authorities, including the FDA, the European Medicines Agency (EMA), the European Directorate for the Quality of Medicines (EDQM), the Southern Kaduna Fulani Development Association (SKFDA), the Polish Main Pharmaceutical Inspectorate, the Pharmaceuticals and Medical Devices Agency (PMDA) and Brazilian health regulatory agency ANVISA.

Strict compliance with cGMP procedures, well-documented standards of practice (SOP), and a modern quality control laboratory also ensures that all APIs produced by Polpharma are of the highest quality.

Finished dosage forms

More than 20 years of experience in supplying finished dosage form (FDF) products demonstrates Polpharma as a reliable partner that anticipates its customers’ needs.

The company’s main objective is a successful product launch at day zero of patent expiry to enable partners to gain optimal market share and sales throughout the product’s entire lifecycle.

Polpharma’s expertise in the generics market guarantees a successful launching process and minimal risk due to a non-interrupted supply and 2×2 API and manufacturer strategy for blockbuster products.

The company has an extensive portfolio of comprehensive common technical document (CTD) dossiers, which meet EU requirements and comply with good manufacturing practices (GMP).

Contract manufacturing organisation services for medical products

The company offers customised contract manufacturing services, with full analytical support in its five European cGMP-compliant production plants. Polpharma has broad experience in the production of both prescription (Rx) and over-the-counter (OTC) drugs, dietary supplements, medical devices, and cosmetics.

High-quality standards, combined with project management and competitive pricing, makes Polpharma an ideal contract manufacturing organisation (CMO) for pharmaceutical companies interested in outsourcing their manufacturing activities.

Drug master file (DMF) documentation for all Polpharma’s products are prepared in accordance with the latest EDQM, International Council for Harmonisation of Technical Requirements (ICH), PMDA and the FDA.

Polpharma CDMO service

Polpharma is a European API producer with cGMP-compliant and FDA-approved multi-purpose facilities. It also provides a CDMO service.

The company’s custom development and manufacturing services are dedicated to clients looking for a European manufacturing site for their active substances.

With broad experience in complex chemistries, dedicated project management and R&D team, corporate quality system and service excellence, we deliver tailored solutions to meet your every need.

Polpharma B2B’s strengths and expertise within CDMO include:

  • Successful tracking of FDA inspections
  • Development from lab to market
  • Professional project management
  • World-class regulatory service
  • State-of-the-art R&D
  • cGMP pilot plant
  • Comprehensive experience
  • Easy-access location

About Polpharma

Polpharma’s portfolio includes 700 products, with another 250 being developed. The company is expanding its branded generic / over-the-counter (OTC) business, food supplements, and medical devices from Poland to other markets, with a primary focus on Central and Eastern Europe (CEE) and Commonwealth of Independent States (CIS) regions.

The company offers Rx and OTC medicines, as well as pharmaceuticals that are restricted to hospital use, food supplements, and medical devices. Polpharma’s key therapeutic areas are cardiology, gastroenterology, neurology, dermatology, respiratory, anti-infectious and ophthalmic drugs.

Make an enquiry

Press Release

Polpharma B2B Announces New Vice-President

Simon Clark has joined Polpharma as vice-president of the management board and chief commercial officer of Polpharma Group.

White Papers

Polpharma B2B’s API Product List

This whitepaper showcases Polpharma B2B's product pipeline of active pharmaceutical ingredients (API) in development, including Apixaban, Baricitinib and Rivaroxaban.

Polpharma B2B

Pharmaceutical Works

Pelpińska 19

83-200 Starogard Gdański


+48 22 364 64 11 +48 22 364 61 62 www.polpharmab2b.com www.api.polpharma.com www.polpharma.pl/ www.linkedin.com/company/polpharma

Polpharma B2B Images

Press Release

25 March 2019

Simon Clark has joined Polpharma as vice-president of the management board and chief commercial officer of Polpharma Group.

Read more
28 September 2018

Polpharma B2B's team of experts will be pleased to meet you at the CPhI Worldwide in Madrid

Read more
11 September 2018

Polpharma B2B has announced it will be attending CPhI Worldwide 2018 in Madrid.

Read more
7 June 2018

One of the most prominent industry events in the Asian region is coming soon. Polpharma B2B has announced it will take a part in key event for the pharmaceutical industry, CPhI China 2018.

Read more
16 May 2018

Polpharma is a manufacturing company, and all manufacturing processes have an impact on the environment and environmental resources.

Read more
22 February 2018

Polpharma B2B has announced it will be attending DCAT WEEK NYC, a business event for pharmaceutical development and manufacturing companies.

Read more
4 January 2018

Last year was full of fruitful meetings that strengthened business relationships. This year, Polpharma B2B continues its presence at key trade shows to discuss the possibility of its B2B offer and find the perfect solutions to your challenges.

Read more
19 December 2017

Polpharma has announced that the Main Pharmaceutical Inspectorate (MPI) have completed two inspections at its active pharmaceutical ingredients (API) plant in Poland.

Read more
7 November 2017

Polpharma B2B has announced it will take part in 19th edition of Pharmtech & Ingredients.

Read more
31 May 2017

Polpharma B2B has announced it will be participating in key event for the pharmaceutical industry in Asia, CPhI China.

Read more
11 May 2017

Polpharma B2B has announced it will be present at the CPhI North America in Philadelphia, PA.

Read more
22 September 2016

Polpharma has won first place in Poland's Most Attractive Employers survey in the Natural Science category.

Read more
11 June 2015

Polpharma will be attending CPHI Shanghai 2015 from 24-26 June.

Read more

Regional Offices

Polpharma B2B

Pharmaceutical Works

Pelpińska 19

83-200 Starogard Gdański


+48 22 364 64 11 +48 22 364 61 62 www.polpharmab2b.com www.api.polpharma.com www.polpharma.pl/ www.linkedin.com/company/polpharma
Strategic Partner, Farmaprojects

Santa Eulalia 240-242

L'Hospitalet de Llobregat




+34 93 508 05 00 +34 93 508 05 01
Contract Manufacturing

ul Łokietka 10

98-200 Sieradz


+48 43 829 92 39 +48 43 829 92 31 +48 43 829 92 41
Latvia, Lithuania

18, E Ozeskienes St

LT-3000 Kaunas


+370 373 251 31 +370 373 251 31 www.polpharma.lt

7-409, Bechterewa St

220026 Mińsk


+375 172 91 59 98 +375 172 91 59 98 www.by.polpharma.com

8, Illinskaya Str

11 Entrance, Floor 5

04070 Kiev


+380 44 498 90 07 +380 44 498 93 87 www.polpharma.ua

Al-Farabi ave. 17/1

Business center ‘Nurly Tau’ 5B, 19th floor

050013 Almaty


+772 73 111 289 298 +772 72 584 348 www.kz.polpharma.com

Polskie Lekarstva LLC

Kosmodamianskaya Naberezhnaya 52, bld 5

115054 Moskwa


+74 95 721 36 97 (98) +74 95 231 79 76 +74 95 723 72 89 www.polpharma.ru

Chekhov St. 32

100031 Tashkent


+998 711 403 026/027 www.uz.polpharma.com
Azerbaijan, Armenia, Georgia

Caspian Business Centre

Dj Djabbarli St 44

Az 1065



+994 12 497 07 15 +994 12 497 07 15 www.az.polpharma.com www.am.polpharma.com www.ge.polpharma.com
Czech Republic

Organizační Složka

Květnového vítězství 332/31

149 00 Praha - Chodov

Czech Republic

+420 272 656 940 +420 272 681 435 www.cz.polpharma.com

Polpharma Bulgaria

85 ‘Z’ Simeonovsko shousse blvd

Office center Magnolia, entrance B, floor 5, office 10

1700 Sofia



59 A Ly Thai To Street

th floor, 425 Room

Hoan Kiem District



Polpharma SA Trade Office

6 Bobrowiecka Street




+48 22 364 64 11
Contract Manufacturing

10 Łokietka Street



+48 43 829 92 39 www.polpharmab2b.com/cm

Go Top